ReleaseWire Connect

Ophthalmology surgery devices are used for studying, diagnosing, and treating ocular disorders. Eyes are sensory organs, which need protection from inflammation, infection, and trauma to maintain a normal vision. These devices help surgeons to diagnose without hurting any other part of an eye. The instruments used in the ophthalmology surgery are Toric Marker, pre-chopper, phoropter, iris forceps, contact lenses, tonometers, speculum, and others. The rising incidences of ocular disorders and technological advancements open new pathways for the ophthalmology surgery devices.

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in loss of vision and permanent eye damage that arises with the development of infections such as glaucoma, retinal edema or cataract. Anterior uveitis can be treated with eye drops containing anti-inflammatory drugs. It usually responds well to treatment. However, there may be a tendency of the condition to re-occur. Uveitis remains a less-explored research indication that involves diverse therapeutics as treatment options including corticosteroids and biologics. Corticosteroids showed significant results to cure the condition and researchers are currently exploring biological therapies to treat anterior uveitis. Introduction of biologics such as Humira (Adalimumab) for the treatment uveitis is driving the growth of anterior uveitis market in Asia pacific. Exploring new drugs and expanding therapeutic applications of existing drugs to include and effectively treat uveitis offers significant growth opportunity for companies involved in uveitis market.

Picture Archiving and Communication System (PACS) is a medical imaging technology which provides storage and access to images for multiple applications. Departmental PACS enables timely access to images, departmental data, and interpretations. It eliminates the need to carry hard copies and allows images to be stored in digital format. Radiology personnel can manage patient records, and access information from different locations. Interfacing with various automation systems within hospital or institutions is a prime benefit of departmental PACS technology.

Colonoscopy devices are used for internal examination of large intestine or colon as well as rectum. These devices come with a small camera connected to a flexible tube. Furthermore, the tube examines the complete length of the large intestine. The procedure can even detect the early stage of colorectal cancer. Doctors often find the device useful in detecting the reason for changes in bowel movements, abnormal growth, abdominal pain and other problems.

The global pharmaceutical contract manufacturing market represents one of the fastest growing markets and it is expected to proffer enormous opportunities in the near future. Contract manufacturing contributes significantly to the overall outsourcing market, owing to its popularity and widespread adoption by pharmaceutical companies. Cost containment issues resulted from global economic constraints, have exerted extensive pressure on pharmaceutical manufacturers to reduce the cost of products. Hence, to make way out of this situation, pharma companies are looking to reduce the manufacturing cost. Contract manufacturing, as a strategic option, offers the certain benefits such as cost reduction, improved product quality, product portfolio and reduction in time to market. Contract manufacturing also support the pharmaceutical companies to focus on R&D and marketing activities by minimizing the time and efforts invested in manufacturing activity. Hence, contract manufacturing is the largely accepted trend in the recent years. HAUPT Pharma AG, Abbott Laboratories, NextPharma, Catalent Pharma Solutions, Althea Technologies, Jubilant Life Sciences Limited, Royal DSM N.V and Nipro Corp. are some of the big players of this market. Patent expiration of major therapeutic brands, growing demand for generic drugs and adoption of novel manufacturing technologies are expected to boost the growth of this market.

Drug discovery is the process by which new medications are discovered. It uses vast array of technologies in the process. Drug discovery technologies are used for the research and the launch of new drugs. Increased use of therapeutics in various diseases has created the need for drug discovery. Recently, with the development of technology, many new types of techniques such as nanotechnology and RNA interference are being used for the purpose of drug discovery. This has created the opportunities for drug discovery technology manufacturers in the new segments. The increasing incidences of diseases, patent expiries, pathogen resistance to old drugs and fierce competition among drug manufacturers are the key factors, which would drive the growth of drug discovery technologies market during the analysis period. Furthermore, in order to earn additional margins, the pharmaceutical companies are in pursuit of blockbuster drugs, which has increased the demand for drug discovery technologies. Factors restraining the market growth are long duration of drug discovery process, high initial setup cost and presence of stringent regulatory environment.

Revenue cycle management (RCM) system is used for tracking financial records in healthcare facilities. The system includes tracking from registration and appointment to final payment of services. It integrates business sides and clinical sides, such as personal information of patients, insurance provider, and treatment received by patients. The time between providing service and receiving payment is reduced by interfacing various IT systems together. Patients can pay bills online, receive updates about upcoming appointments, and lessen the amount of denied claims with the help of RCM system.

Cell surface markers are protein or antigenic determinants found on the surface of specific types of cells. They also act as a marker for identifying the specific type of cell. Determination of ligands or drug response in research activities is done through cell surface marker analysis.

Chiral separation column is a technique in which two enantiomers of the same compound with different affinity are separated. The chiral separation is significant, because most of the bioorganic molecules in human body are chiral. It helps in developing technology for analysis and separation of racemic drugs in pharmaceutical industries. The preparation of pure optically active compounds and determination of reaction mechanism & pathways are carried out using chiral separation columns in laboratories.

World Health Organization (WHO) projects that the global count of people aged above 65 years, will reach 2 billion by 2050. With the rising geriatric populations, due to several age related conditions, there will be more surgical procedures, which will increase the demand for hemostasis and tissue sealing agents. Hemostasis and tissue sealing agents are used to prevent hemorrhage. During a surgery it is very important to stop the excessive bleeding of the patient, to avoid further damage or death by blood loss. This has created the need for hemostasis and tissue sealing agents. The increasing number of surgeries, introduction of multi-usage and ready-to-use products along with the global rise in geriatric populations supplement the growth of the global hemostasis and tissue sealing agents market during the analysis period. Recently, the FDA has approved numerous hemostatic products that would further drive the growth of global hemostasis and tissue sealing agents market. Factors restraining the market growth are high prices of the products and stringent regulatory environment.